Over 1850 Total Lots Up For Auction at Six Locations - MA 04/30, NJ Cleansweep 05/02, TX 05/03, TX 05/06, NJ 05/08, WA 05/09

Breast cancer screening gets personal

by Lisa Chamoff, Contributing Reporter | July 19, 2021
Women's Health
From the July 2021 issue of HealthCare Business News magazine


The solution, designed for diagnosis, screening and follow-up in the case of suspected lesions, is available on EPIQ and Affiniti ultrasound systems. Recently, the monitor size has also been increased to 24 inches with the HD MAX monitor, said Radjen Ganpat, marketing manager for Ultrasound at Philips.

Current customers can upgrade to the latest enhancements.

Qlarity Imaging QuantX
Qlarity Imaging
Qlarity Imaging is moving its QuantX AI-based decision support software, for helping radiologists in the assessment and characterization of breast abnormalities during breast MR exams, from a traditional dedicated workstation to a vendor-neutral, cloud-based format. This will allow radiologists to use their own viewer and leverage their existing PACS environment, access the secure application anywhere and automatically export their findings into the reporting software.

“We reimagined what breast radiologists need from their technology tools,” said Jon T. DeVries, the chief executive officer of Qlarity Imaging. “With this new format, our goal is to address many of the current challenges health systems and radiologists face and encourage scalable technology that strengthens our vision of transforming the patient journey, including new developments in screening procedures.”

The company plans to submit the new release to the FDA this month and is aiming for clearance in the fourth quarter of 2021.

QT Imaging views
QT Imaging
QT Imaging has developed a technology called Quantitative Transmission (QT) ultrasound, which uses transmitted sound waves to create three dimensional images of the breast. The technology is different from reflection ultrasound, using 2048 cameras and a water bath to image the breast without compression.

The technology is currently used for both regular and adjunctive screening, and the company is looking to eventually provide an alternative to screening mammography, said John Klock, chief executive officer and chief medical officer of QT Imaging.

You Must Be Logged In To Post A Comment